Zydus Pharmaceuticals (USA) Inc FDA Inspection Record
Zydus Pharmaceuticals (USA) Inc is an FDA-inspected facility (FEI 3008444937) located in Pennington, NJ, US. RegDataLab tracks 5 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Feb 27, 2020: No Action Indicated (NAI)
- Inspections on record
- 5 (1 VAI, 4 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 55, latest Oct 1, 2026
- Import refusals
- 6
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Feb 27, 2020 | No Action Indicated (NAI) | No citations listed |
| May 15, 2014 | No Action Indicated (NAI) | No citations listed |
| Feb 22, 2011 | Voluntary Action Indicated (VAI) | Failure to review ADE information (21 CFR 314.80(b)) |
| Jun 14, 2010 | No Action Indicated (NAI) | No citations listed |
| Aug 11, 2009 | No Action Indicated (NAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Oct 1, 2026 | Class II | D-0039-2027 | Hydrocortisone Sodium Succinate for Injection, USP 100 mg/vial, 1 Vial, Rx Only… Failed Impurities/Degradation Specifications. |
| Aug 5, 2026 | Class II | D-0745-2026 | Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by… CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity. |
| Apr 29, 2026 | Class II | D-0544-2026 | Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus… and 1 more product CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit |
| Mar 9, 2026 | Class II | D-0400-2026 | Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured by… Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient. |
| Dec 30, 2025 | Class II | D-0295-2026 | Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel… Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules |
| Dec 19, 2025 | Class III | D-0247-2026 | traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by… Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface. |
| Oct 23, 2025 | Class II | D-0159-2026 | Bromocriptine Mesylate Capsules, USP, 5 mg, 30 Capsules per bottle, Rx Only. Manufactured… Failed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine… |
| Oct 22, 2025 | Class II | D-0152-2026 | clomiPRAMINE Hydrochloride, Capsules, USP, 25 mg, packaged in a) 30-count bottles (NDC… and 2 more products cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso… |
| Sep 24, 2025 | Class II | D-0001-2026 | Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus… and 1 more product Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity |
| Sep 4, 2025 | Class II | D-0656-2025 | Entecavir Tablets, USP, 0.5 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences… and 1 more product Failed Impurity/Degradation Specifications |
FDA record score
91 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
44 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class II recall D-0039-2027, this FEI as the recalling firm | Oct 1, 2026 | 4 x 1 | 4 |
| Class II recall D-0745-2026, this FEI as the recalling firm | Aug 5, 2026 | 4 x 1 | 4 |
| Class II recall D-0544-2026, this FEI as the recalling firm | Apr 29, 2026 | 4 x 1 | 4 |
| Class II recall D-0400-2026, this FEI as the recalling firm | Mar 9, 2026 | 4 x 1 | 4 |
| Class II recall D-0295-2026, this FEI as the recalling firm | Dec 30, 2025 | 4 x 1 | 4 |
| Class II recall D-0159-2026, this FEI as the recalling firm | Oct 23, 2025 | 4 x 1 | 4 |
| Class II recall D-0152-2026, this FEI as the recalling firm | Oct 22, 2025 | 4 x 1 | 4 |
| Class II recall D-0001-2026, this FEI as the recalling firm | Sep 24, 2025 | 4 x 1 | 4 |
| Class II recall D-0656-2025, this FEI as the recalling firm | Sep 4, 2025 | 4 x 1 | 4 |
| Class II recall D-0630-2025, this FEI as the recalling firm | Sep 3, 2025 | 4 x 1 | 4 |
| Class II recall D-0623-2025, this FEI as the recalling firm | Aug 27, 2025 | 4 x 1 | 4 |
| Class II recall D-0497-2025, this FEI as the recalling firm | May 30, 2025 | 4 x 1 | 4 |
| Class II recall D-0442-2025, this FEI as the recalling firm | May 13, 2025 | 4 x 1 | 4 |
| Class II recall D-0361-2025, this FEI as the recalling firm | Apr 3, 2025 | 4 x 1 | 4 |
| Class II recall D-0310-2025, this FEI as the recalling firm | Mar 21, 2025 | 4 x 1 | 4 |
| Class II recall D-0255-2025, this FEI as the recalling firm | Feb 13, 2025 | 4 x 1 | 4 |
| Class I recall D-0315-2021, this FEI as the recalling firm | Feb 18, 2021 | 15 x 0.25 | 3.8 |
| Class II recall D-0600-2024, this FEI as the recalling firm | Jun 27, 2024 | 4 x 0.6 | 2.4 |
| Class II recall D-0617-2024, this FEI as the recalling firm | Jun 21, 2024 | 4 x 0.6 | 2.4 |
| Class II recall D-0096-2024, this FEI as the recalling firm | Oct 19, 2023 | 4 x 0.6 | 2.4 |
| Class II recall D-0038-2024, this FEI as the recalling firm | Sep 21, 2023 | 4 x 0.6 | 2.4 |
| Class II recall D-1351-2022, this FEI as the recalling firm | Jul 15, 2022 | 4 x 0.6 | 2.4 |
| Class II recall D-0753-2021, this FEI as the recalling firm | Aug 13, 2021 | 4 x 0.25 | 1 |
| Class II recall D-0145-2021, this FEI as the recalling firm | Dec 3, 2020 | 4 x 0.25 | 1 |
| Class II recall D-0074-2021, this FEI as the recalling firm | Oct 27, 2020 | 4 x 0.25 | 1 |
| Class II recall D-0834-2020, this FEI as the recalling firm | Jan 31, 2020 | 4 x 0.25 | 1 |
| Class II recall D-1440-2019, this FEI as the recalling firm | May 6, 2019 | 4 x 0.25 | 1 |
| Class II recall D-1272-2019, this FEI as the recalling firm | Apr 25, 2019 | 4 x 0.25 | 1 |
| Class II recall D-0101-2018, this FEI as the recalling firm | Nov 20, 2017 | 4 x 0.25 | 1 |
| Class II recall D-1137-2017, this FEI as the recalling firm | Aug 18, 2017 | 4 x 0.25 | 1 |
| Class II recall D-1041-2017, this FEI as the recalling firm | May 10, 2017 | 4 x 0.25 | 1 |
| Class II recall D-0617-2017, this FEI as the recalling firm | Mar 15, 2017 | 4 x 0.25 | 1 |
| Class II recall D-0605-2017, this FEI as the recalling firm | Mar 6, 2017 | 4 x 0.25 | 1 |
| Class II recall D-1460-2016, this FEI as the recalling firm | Jul 19, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1491-2016, this FEI as the recalling firm | May 9, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall D-0325-2015, this FEI as the recalling firm | Dec 23, 2014 | 10 years or older, so it adds no points | 0 |
| Class II recall D-0299-2015, this FEI as the recalling firm | Nov 26, 2014 | 10 years or older, so it adds no points | 0 |
| Class II recall D-0015-2015, this FEI as the recalling firm | Sep 15, 2014 | 10 years or older, so it adds no points | 0 |
| Class II recall D-0007-2015, this FEI as the recalling firm | Aug 5, 2014 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1342-2014, this FEI as the recalling firm | May 8, 2014 | 10 years or older, so it adds no points | 0 |
| Class I recall D-838-2013, this FEI as the recalling firm | May 13, 2013 | 10 years or older, so it adds no points | 0 |
| Class II recall D-202-2013, this FEI as the recalling firm | Mar 5, 2013 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1428-2012, this FEI as the recalling firm | Mar 14, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Feb 22, 2011 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Zydus Pharmaceuticals (USA) Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Zydus Pharmaceuticals (USA) Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Zydus Pharmaceuticals (USA) Inc
- Location
- Pennington, NJ (US)
- Source
- inspections